1-3 of 3
Katina DeShong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery

Available to Purchase
Tracy M. Downs, Howard H. Bailey, Taja Lozar, Natalie S. Schmitz, Heather Green, Cameron O. Scarlett, Thomas C. Havighurst, Kyleigh Twaroski, Katina DeShong, Barbara Wollmer, Trinity J. Bivalacqua, Daniel R. Saltzstein, Neal Shore, KyungMann Kim, Wei Huang, William A. Ricke, Lisa Barroilhet, Margaret House, Howard L. Parnes, Edward Messing
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2025) 18 (1): 31–39.
https://doi.org/10.1158/1940-6207.CAPR-24-0194
Published: 06 January 2025
View articletitled, Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery
Open the PDF for Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery in another window
Journal Articles

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs

Available to Purchase
Goli Samimi, Margaret House, Kelly Benante, Lisa Bengtson, Troy Budd, Bridget Dermody, Katina DeShong, Valerie Dyer, Bruce F. Kimler, Vikrant V. Sahasrabuddhe, Suzanne Siminski, Leslie G. Ford, Eduardo Vilar, Eva Szabo
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (5): 279–284.
https://doi.org/10.1158/1940-6207.CAPR-21-0578
Published: 03 May 2022
View articletitled, Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs
Open the PDF for Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs in another window
Journal Articles

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers

Free
Jill M. Kolesar, Shannon Andrews, Heather Green, Tom C. Havighurst, Barbara W. Wollmer, Katina DeShong, Douglas E. Laux, Helen Krontiras, Donald D. Muccio, KyungMann Kim, Clinton J. Grubbs, Margaret G. House, Howard L. Parnes, Brandy M. Heckman-Stoddard, Howard H. Bailey
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2019) 12 (12): 903–912.
https://doi.org/10.1158/1940-6207.CAPR-19-0310
Published: 03 December 2019
View articletitled, A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers
Open the PDF for A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers in another window